- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05481398
A Randomized Controlled Trial Evaluating the Role of Negative Pressure Wound Therapy (NPWT) for Incisional Surgical Site Infections in Patients Undergoing Hepatopancreatobiliary Surgery (NPWT)
July 28, 2022 updated by: Murk Niaz
Negative Pressure Wound Therapy (NPWT) for Incisional Surgical Site Infections in Patients Undergoing Hepatopancreatobiliary Surgery: A Randomized Controlled Trial.
To compare the rates of incisional surgical site infections (iSSIs) within 7 days of hepatopancreatobiliary (HPB) surgery using negative pressure wound therapy (NWPT) versus using standard sterile gauze dressing.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
46
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Sindh
-
Karachi, Sindh, Pakistan
- Sindh Institute of urology and Transplantation
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
All patients undergoing elective open HPB surgery (benign or malignant disease) of age > 18 years consenting to the study protocol.
Exclusion Criteria:
The patient in which primary wound closure is not achieved. The patient planned for a second look surgery. The patient with the history of long-term antibiotic use (more than a month). Past history of open abdominal surgery (less than 1 month).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Intervention group A
After the skin closed, negative pressure wound therapy will be applied.
|
The wound is dressed using negative pressure wound therapy comprising of a single layer of sterile gauze followed by placement of a 18 Fr nelaton catheter and the wound further covered with 4 more layers of sterile gauze over the nelaton catheter.
The wound is then covered with opsite dressing making it airtight.
The nelaton catheter is attached to the wall suction port once the patient is shifted to the bed with pressure set at - 25 mm Hg.
|
|
NO_INTERVENTION: Control group B
After the skin is closed, the wound is covered using sterile standard guaze dressing.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of incisional surgical site infections (iSSIs)
Time Frame: within 7 days of hepatopancreatobiliary (HPB) surgery
|
To compare the rates of incisional surgical site infections (iSSIs) within 7 days of hepatopancreatobiliary (HPB) surgery using negative pressure wound therapy (NWPT) versus using standard sterile gauze dressing.
|
within 7 days of hepatopancreatobiliary (HPB) surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Wound infections
Time Frame: day 7 till 30 days following HPB surgery
|
Wound infections after day 7 till 30 days following HPB surgery.
|
day 7 till 30 days following HPB surgery
|
|
Surgical site complication
Time Frame: within 30 days of HPB surgery
|
Surgical site complication (hematoma/seroma/wound dehiscence) within 30 days of HPB surgery.
|
within 30 days of HPB surgery
|
|
Rate of fascial dehiscence
Time Frame: within 30 days of HPB surgery
|
Rate of fascial dehiscence within 30 days of HPB surgery.
|
within 30 days of HPB surgery
|
|
Antibiotic therapy
Time Frame: Day 1 to day 30
|
Need for antibiotic therapy for iSSI beyond perioperative/postoperative surgical prophylaxis.
|
Day 1 to day 30
|
|
Length of hospital stay.
Time Frame: Day 1 to day 30
|
Length of hospital stay.
|
Day 1 to day 30
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Uzma Soomro, Sindh Institute of urology and Transplantation
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
March 6, 2021
Primary Completion (ACTUAL)
July 1, 2022
Study Completion (ACTUAL)
July 1, 2022
Study Registration Dates
First Submitted
July 28, 2022
First Submitted That Met QC Criteria
July 28, 2022
First Posted (ACTUAL)
August 1, 2022
Study Record Updates
Last Update Posted (ACTUAL)
August 1, 2022
Last Update Submitted That Met QC Criteria
July 28, 2022
Last Verified
July 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NPWT HPB
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Surgical Site Infection
-
Gundersen Lutheran Medical FoundationGundersen Lutheran Health SystemCompletedSurgical Site Infection | Superficial Surgical Site Infection | Deep Surgical Site Infection | Organ/Space Surgical Site InfectionUnited States
-
King Faisal Specialist Hospital & Research CenterEnrolling by invitationSurgical Site Infections | Surgical Site Infection After Major SurgerySaudi Arabia
-
Singapore General HospitalNovem Healthcare Pte LtdTerminatedSuperficial Surgical Site InfectionSingapore
-
Halmstad County HospitalCompleted
-
MinaPharm PharmaceuticalsRecruitingSurgical Site InfectionsEgypt
-
Karolinska University HospitalStockholm South General HospitalRecruitingPostoperative Surgical Site InfectionSweden
-
Washington University School of MedicineCompleted
-
Region SkaneVinnovaCompleted
-
Population Health Research InstituteCompletedSurgical Site InfectionsCanada
-
University of RochesterSage Products, Inc.Completed
Clinical Trials on Negative Pressure Wound Therapy
-
ConvaTec Inc.WithdrawnSurgical Wound, Recent | Trauma-related Wound | Dehiscence Wound | Surgical Wound LeakUnited States
-
Sindh Institute of Urology and TransplantationCompletedSurgical Site Infection | Wound Heal | Negative-Pressure Wound Therapy | Stoma Site InfectionPakistan
-
Henry Ford Health SystemWithdrawnSurgical Site Infection | Groin InfectionsUnited States
-
Region SkaneRecruitingPostoperative Complications | Surgical Wound Infection | Skin Cancer | Wound Healing | Bandages | Negative-Pressure Wound Therapy | Skin Grafting | Lower Extremity | Skin Transplantation | Split Thickness Skin Graft | Skin Tumour | LegSweden
-
Zuyderland Medisch CentrumCompletedBreast Cancer | Wound Infection | Wound Complication | Wound Dehiscence | Wound NecrosisNetherlands
-
H. Lee Moffitt Cancer Center and Research InstituteActive, not recruitingSurgical Wound InfectionUnited States
-
HealthPartners InstituteUniversity of MinnesotaRecruitingNecrotizing Soft Tissue InfectionsUnited States
-
Royal College of Surgeons, IrelandRecruitingWound Healing | Pilonidal SinusIreland
-
Zuyderland Medisch CentrumRecruitingBreast Cancer | Seroma | Wound ComplicationNetherlands